Nov 14 (Reuters)-
Shin Nippon Biomedical Laboratories Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2017 Sep 30, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 7.55 7.08 16.25
(+6.6 pct) (+7.9 pct) (-5.8 pct)
Operating loss 779 mln loss 1.71 loss 1.10
Recurring loss 640 mln loss 2.91 loss 1.22
Net loss 1.65 loss 2.89 loss 1.50
EPS loss 39.63 yen loss 70.66 yen loss 36.02 yen
Ann Div NIL
-Q2 div NIL NIL
-Q4 div NIL
NOTE - Shin Nippon Biomedical Laboratories Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T
((Tokyo Headline News Desk +813 6441 1812))